Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Research & Development: 2011-2024

Historic Research & Development for MediWound (MDWD) over the last 14 years, with Dec 2024 value amounting to $8.9 million.

  • MediWound's Research & Development rose 37.28% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 66.60%. This contributed to the annual value of $8.9 million for FY2024, which is 18.90% up from last year.
  • As of FY2024, MediWound's Research & Development stood at $8.9 million, which was up 18.90% from $7.5 million recorded in FY2023.
  • MediWound's 5-year Research & Development high stood at $10.3 million for FY2021, and its period low was $7.5 million during FY2023.
  • Over the past 3 years, MediWound's median Research & Development value was $8.9 million (recorded in 2024), while the average stood at $8.8 million.
  • In the last 5 years, MediWound's Research & Development spiked by 54.92% in 2020 and then declined by 26.66% in 2023.
  • Over the past 5 years, MediWound's Research & Development (Yearly) stood at $7.7 million in 2020, then spiked by 33.23% to $10.3 million in 2021, then declined by 0.73% to $10.2 million in 2022, then declined by 26.66% to $7.5 million in 2023, then grew by 18.90% to $8.9 million in 2024.